How is India contributing to global clinical trials?

India is a critically important backbone for global clinical trials, demonstrating resilience and ensuring business continuity for research operations.

What is the impact of artificial intelligence on healthcare roles in India?

Artificial intelligence presents opportunities to elevate professional roles in healthcare by automating routine tasks, thereby increasing speed, accuracy, and quality.

What is Parexel's perspective on India's role in clinical research?

Parexel views India as essential for maintaining global clinical trial business continuity and sees its talent driving innovations in research and safety.

Home / Business and Economy / India Powers Global Clinical Trials Amidst Turmoil

India Powers Global Clinical Trials Amidst Turmoil

15 Feb

•

Summary

India is a vital backbone for global clinical trials.
AI presents opportunities to elevate healthcare professional roles.
Parexel sees India as critical for business continuity.

India Powers Global Clinical Trials Amidst Turmoil

India has solidified its position as a critical hub for international clinical trials, proving resilient against global challenges such as geopolitical instability and evolving regulatory landscapes. Companies like Parexel emphasize India's indispensable contribution to ensuring consistent business operations and the scientific accuracy of global research endeavors.

Peyton Howell, CEO of Parexel, a leading clinical research organization, described India as a "critically important backbone" for clinical trials. The country's role is expanding as the industry navigates supply chain disruptions and protectionist trade policies. Parexel, with 6,000 employees in India, relies on its Indian operations to support global trial continuity.